| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 02/21/2008 | US20080045544 Phenyl, Pyridine, Quinoline, Isoquinoline, Naphthyridine and Pyrazine Derivatives |
| 02/21/2008 | US20080045541 Dihydropyridinone Derivatives |
| 02/21/2008 | US20080045527 Immunomodulating Heterocyclic Compounds |
| 02/21/2008 | US20080045521 Phenylalanine derivatives |
| 02/21/2008 | US20080045514 3-Aryl-6-aryl-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 02/21/2008 | US20080045511 3-chloro-5-[6-chloro-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)-phenoxy]-benzonitrile; inhibit HIV reverse transcriptase and are useful for treating Human Immunodeficiency Virus (HIV) mediated diseases |
| 02/21/2008 | US20080045500 Nerve Regeneration Stimulator |
| 02/21/2008 | US20080045498 Polycyclic viral inhibitors |
| 02/21/2008 | US20080045496 Inhibit tyrosine kinase activity of Trk receptors; antiproliferative agents, anticancer agents; cancer, psoriasis or rheumatoid arthritis; N4-pyrazol-5-yl-pyrrolo[2,1-f] [1,2,4]triazine-2,4-diamines |
| 02/21/2008 | US20080044354 Compounds Containing a N-Heteroaryl Moiety Linked to Fused Ring Moieties for the Inhibition of Nad(P)H Oxidases and Platelet Activation |
| 02/21/2008 | CA2660974A1 Modulators of muscarinic receptors |
| 02/21/2008 | CA2660899A1 Tricyclic compound derivatives useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders |
| 02/21/2008 | CA2660836A1 Triazolotriazines as kinase inhibitors |
| 02/21/2008 | CA2660799A1 Pyrrolo[2,1-c][1,4]benzodiazepine hybrids and a process for the preparation thereof |
| 02/21/2008 | CA2660441A1 Imidazole amines as inhibitors of .beta.-secretase |
| 02/21/2008 | CA2658984A1 Non-nucleoside reverse transcriptase inhibitors |
| 02/20/2008 | EP1889847A1 Pyrrolopyrimidines for pharmaceutical compositions |
| 02/20/2008 | EP1889639A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents, for producing long lasting antineoplastic agents |
| 02/20/2008 | EP1888707A1 New materials for organic electroluminescence devices |
| 02/20/2008 | EP1888594A2 Gabaergic agents to treat memory deficits |
| 02/20/2008 | EP1888591A2 Derivatives of 6,7-dihydro-5h-imidazo[1,2-a]imidazole-3-sulfonic acid |
| 02/20/2008 | EP1888590A2 Crystalline forms of a pyrrolotriazine compound |
| 02/20/2008 | EP1888589A2 Pyrrolopyridine-based inhibitors of dipeptidyl peptidase iv and methods |
| 02/20/2008 | EP1888588A2 Protein kinase inhibitors |
| 02/20/2008 | EP1888550A2 Apoptosis promoters |
| 02/20/2008 | EP1888534A2 Organic compounds |
| 02/20/2008 | EP1888530A2 Quinoline derivatives as neurokinin receptor antagonists |
| 02/20/2008 | EP1888066A2 Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 02/20/2008 | EP1560829B1 Pyrimido compounds having antiproliferative activity (ii) |
| 02/20/2008 | EP1556384B1 Pyrimido compounds having antiproliferative activity |
| 02/20/2008 | EP1556381B1 Pyrazole amides for treating hiv infections |
| 02/20/2008 | EP1383747B1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
| 02/20/2008 | EP1289968B1 Cyclic urea compounds and preparation thereof |
| 02/20/2008 | EP1166784B1 Inhibition of vascular restenosis after angioplasty |
| 02/20/2008 | CN101128474A Tricyclic-nucleoside prodrugs for treating viral infections |
| 02/20/2008 | CN101128466A 5,6-dialkyl-7-amino-azolopyrimidines, method for their production, their use for controlling pathogenic fungi and agents containing said compounds |
| 02/20/2008 | CN101128465A 5,6-dialkyl-7-amino-azolopyrimidines, method for their production, their use for controlling pathogenic fungi and agents containing said compounds |
| 02/20/2008 | CN101125855A Method for separating hemporfin isomer and separated isomer |
| 02/20/2008 | CN100369914C 3-ene-8-ethyl-2,7,12,15,18-pentamethyl-13-carboxylic acid-17-propionic acid amino acid amide, its synthetic method and light power therapeutic medicine |
| 02/20/2008 | CN100369912C Heteroaryl substituted fused bicyclic heteroaryl compounds as GABAA receptor ligands |
| 02/20/2008 | CN100369888C N-alkanoylphenylalanine derivatives |
| 02/19/2008 | US7332599 Methods and intermediates for the synthesis of dipyrrin-substituted porphyrinic macrocycles |
| 02/19/2008 | US7332498 N-(3-amino-propyl)-N-[1-(3-benzyl-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl)-2-methyl-propyl]-4-methyl-benzamide; kinesin spindle protein inhibitor; cell division, mitosis phase arrest; antiproliferative and antiinflammation agent, hyperplasias, restenosis, cardiac hypertrophy, autoimmune disorders |
| 02/19/2008 | US7332497 Pyrazolopyrimidines as therapeutic agents |
| 02/19/2008 | US7332491 cyclin-dependent and serine/threonine kinases inhibitor; cell cycle arrest in the G2/M phase; antiproliferative and antitumor agent: leukemia, sarcoma, lung, breast, prostate, pancreas cancer; autoimmune diseases: arthritis, Alzheimer's disease |
| 02/19/2008 | US7332490 inhibit smooth muscle cell proliferation by modulating Heparan Sulfate Proteoglycans (HSPGs); inhibit or block glycated protein and Advanced Glycation Endproducts (AGE) produced induction of the signaling-associated inflammatory response in endothelial cells; antiproliferative and antiinflammatory agent |
| 02/19/2008 | US7332489 Methods and compositions of novel triazine compounds |
| 02/19/2008 | US7332488 Methods and compositions of novel triazine compounds |
| 02/19/2008 | CA2481723C 5ht2c receptor modulators |
| 02/19/2008 | CA2226582C Non-allosteric gabaa agonists for treating sleep disorders |
| 02/14/2008 | WO2008019292A2 Compositions and methods for potentiating antibiotic activity |
| 02/14/2008 | WO2008018426A1 Pyrimidine derivative as pi3k inhibitor and use thereof |
| 02/14/2008 | WO2008017883A2 4-oxo-4,5-dihydropyrrolo[1,2-a] quinoxaline derivatives as inhibitors of poly(adp-ribose)polymerase(parp) |
| 02/14/2008 | WO2008017688A1 2-carboxy thiophene derivatives as anti-viral agents |
| 02/14/2008 | WO2008017670A1 Pyrrolo [3, 2 -d] pyrimidines as dpp-iv inhibitors for the treatment of diabetes mellitus |
| 02/14/2008 | WO2008017465A1 Bicyclic lactam derivatives, their manufacture and use as pharmaceutical agents |
| 02/14/2008 | WO2007140200A3 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors |
| 02/14/2008 | WO2007138072A3 Triazolopyrazine compounds useful for the treatment of degenerative & inflammatory diseases |
| 02/14/2008 | WO2007117381A3 2 -aminopyridine analogs as glucokinase activators |
| 02/14/2008 | WO2007018248A9 Pyridone compound |
| 02/14/2008 | US20080039479 Compounds and therapeutical use thereof |
| 02/14/2008 | US20080039476 Pyrazolopyrimidines, a process for their preparation and their use as medicine |
| 02/14/2008 | US20080039472 Inhibitors of the Interaction Between Mdm2 and P53 |
| 02/14/2008 | US20080039469 3-Benzyl-3a-cyclobutyl-7-methoxymethyl-2-oxo-octahydro-oxazolo[4,5-c]pyridin-5-ium; useful as agents for stimulating the cognitive functions of the brain |
| 02/14/2008 | US20080039457 Triazolotriazines as kinase inhibitors |
| 02/14/2008 | US20080039455 Pyrazolopyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 02/14/2008 | US20080039449 [1,4]benzodiazepine derivatives, used for treating osteoarthritis, pancreatitis, glomerulonephritis, rheumatoid arthritis, inflammatory bowel disease, Crohn's disease, psoriasis, graft vs host disease, leukemia, septic shock, multiple sclerosis, and inflammatory bowel disease |
| 02/14/2008 | US20080039448 viricides, parasiticide, bactericides, gene therapy and treating cisplatin refractory disease; e.g. 1,1'[[(Propane-1,3-diyl)dioxy]bis(11aS)-11-sulpho-7-methoxy-2-methylidene-1,2,3,10,11,11a-hexahydro-5H-pyrrolo[2,1-c][1,4-benzodiazepin-5-one]] sodium salt |
| 02/14/2008 | US20080039436 Porphyrin Derivatives And Their Use In Photon Activation Therapy |
| 02/14/2008 | CA2660197A1 Pyrrolo[3,2-d]pyrimidines as dpp-iv inhibitors for the treatment of diabetes mellitus |
| 02/14/2008 | CA2659604A1 Pyrimidine derivative as pi3k inhibitor and use thereof |
| 02/14/2008 | CA2659429A1 4-oxo-4,5-dihydropyrrolo[1,2-a]quinoxaline derivatives as inhibitors of poly(adp-ribose)polymerase(parp) |
| 02/13/2008 | EP1886999A2 Bicyclic heteroaromatic compound |
| 02/13/2008 | EP1886994A1 Cyclic amine compounds as CCR5 antagonists |
| 02/13/2008 | EP1885725A1 Tricyclic azole derivatives, their manufacture and use as pharmaceutical agents |
| 02/13/2008 | EP1885713A1 1, 2, 4 -triazole derivatives as vasopressin antagonists |
| 02/13/2008 | EP1885369A2 Fused heterocyclic compounds, and compositions and uses thereof |
| 02/13/2008 | EP1680421B1 Use of tricyclic compounds as glycine transport inhibitors |
| 02/13/2008 | EP1648896B1 7-substituted 3-nitro-pyrazolo [1,5-a] pyrimidines |
| 02/13/2008 | EP1514904B1 µ-OXO CROSSLINKED DISSIMILAR METAL PHTHALOCYANINE COMPOUND AND PROCESS FOR SELECTIVELY PRODUCING THE SAME |
| 02/13/2008 | EP1463716B1 Pyrrolidine and piperidine derivates as nk1 antagonists |
| 02/13/2008 | EP1299390B1 Pyrimidine compounds and their use in the preparation of a triazolo -pyrimidine carba nucleoside |
| 02/13/2008 | EP1292561B1 Process for the preparation of cyclopropyl carboxylic acid esters and derivatives |
| 02/13/2008 | CN101124228A Pyrazolopyrimidine compounds as antitumor agents |
| 02/13/2008 | CN101124227A Imidazo[1,2-a]pyrazin-8-ylamines useful as modulators of kinase activity |
| 02/13/2008 | CN101124226A 1H-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof |
| 02/13/2008 | CN101121717A Synthesis for natural medicament physostigmine for resisting senile dementia disease and phenylaminoformic acid ester phenserine |
| 02/13/2008 | CN100368413C Composition stable blood porphrin derivative, its preparation method and injection agent |
| 02/13/2008 | CN100368412C Substituted 8-perfluoroalkyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives |
| 02/12/2008 | US7329760 CC-1065 analog synthesis |
| 02/12/2008 | US7329754 modulators of the monoamine receptors, in particular the serotonin, dopamine and norepinephrine receptors, and the biogenic amine transporters for serotonin, dopamine and norepinephrine; |
| 02/12/2008 | US7329748 Method for the production of riboflavin of modification b/c in granular form |
| 02/12/2008 | US7329747 Synthesis of olanzapine and intermediates thereof |
| 02/12/2008 | US7329683 Moderation of cortisol; non-insulin dependent diabetes; hypotensive agents; using a 1,2,4 triazole compound |
| 02/12/2008 | US7329668 For therapy of inflammatory diseases, immune diseases, and cancer |
| 02/12/2008 | US7329667 A hexahydro-1,5,6,8-tetraaza-acenaphthylene or -1,3,4-triazaphenalene derivatives; treatment of depression and anxiety; inflammatory bowel disease; treatment of conditions mediated by corticotropin-releasing factor |
| 02/12/2008 | US7329664 Substituted (7-pyridyl-4-phenylamino-quinazolin-2-yl)-methanol analogues |
| 02/12/2008 | US7329663 Substituted-triazolopyrimidines as anticancer agents |
| 02/12/2008 | US7329662 Pyrazolo-pyridine |
| 02/12/2008 | US7329659 Substituted-1-phthalazinamines as vr-1 antagonists |